|
Aigner A
Perspectives, issues and solutions in RNAi therapy:
the expected and the less expected.
Nanomedicine 2019; 14(21):2777-2782
Bochardt H, Schulz A,
Datta K, MudersMH, Aigner A
Silencing of Neuropiling of Neuropilings and GIPC1 in pancreatic
ductual adenocarcinoma exerts
multiple cellular and molecular antitumor effects.
Sci Rep 2019; 9(1):15471
Ewe A, Noske S,
Karimov M, Aigner A
Polymeric Nanoparticles Besed on Tyrosine-Modified, Low Molecular
Weight Polyethylenimines
for siRNA delivery.
Pharmaceutics 2019;11(11):E600
Franke H, Scholl R,Aigner A
Ricin and Ricinus communis in pharmacology and toxicology-from ancient
use and "Papyrus Ebers"
to modern perspectives and "poisonous plant of the year 2018"
Naunyn Schmiedebergs Arch Pharmacol 2019; 392(10):1181-1208
Regenthal R
Potential Drug Interactions Forgotten.
Dtsch Arztebl Int 2019; 116(5):71-72
Wach S, Brandl M,Borchardt H
Weigelt K, Lukat S, Nolte E, Al-Janabi O,
Hart M, Grasser F, Giedl J, Jung R, Stohr R, Hartmann A, Lieb V,
Hobel S Peters A, Staubert C,
Wullich B, Taubert H, Aigner A
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate
Cancer Cells in Vitro
and in Vivo
Mol Ther Nucleic Acids 2019; 16: 272-283
Fingernagel J, Boye S, Kietz A,Hobel
S, Wozniak K, Moreno S, Janke A, Lederer A, Aigner
A, Temme A,
Voit B, Appelhans
Mono- and Polyassociation Processes of Pentavalent Biotinylated PEI
Glycopolymers for
the Fabrication of Biohydrid Structures with Targeting Properties.
Biomarcromolecules 2019; 20(9):3408-3424
Linder B,Weihrauch U, Ewe A,
Uhmann A, Seifert V, Mittelbronn M, Harter PN, Aigner A,
Therapeutic Targeting of Stat Using Lipopolyplex
Nanoparticle-Formulated siRNA in a
Syngeneic Orthotopic Mouse Glioma Model.
Cancers (Basel) 2019; 11(3):E333
Remy J, Linder B, Weirauch U,
Konovalova J, Marschalek R, Aigner A, Kogel D
Inhibition of PIM1 blocks the autophagic flux to sensitize glioblastoma
cells to ABT-737-induced apoptosis.
Biochim Biophys Acta Mol Cell Res 2019; 1866(2):175-189
Ressing N, Marquardt V, Gertzen CGW, Scholer
A, Schramm A, Kurz T, Gollke H, Aigner A, Remke M,
Hansen FK
Design, synthesis and biological evaluation of beta-peptoid-capped HDAC
inhibitors with anti-neuroblastoma
and anti-glioblastoma activity.
Medchemcomm 2019; 10(7):1109-1115
van der Voort T, Brinkman DJ, Benemei S,
Bottiger Y, Chamontin B, Christiaens T,
Lidic R,Regenthal R, Sanz EJ, Wilson K, Tichelaar J,
van Agtmael MA
Appropriate antibiotic prescribing among final-year medical students in
Europe.
Int J Antimicrob Agents 2019; 54(3):375-379
|